January 7, 2020   TAPERING BIOLOGICS   11 Considerations for Tapering Biologic Therapy in Inflammatory Arthritis In a review published last month in Autoimmunity Reviews, British researchers outline factors physicians should consider when contemplating tapering biologic therapies in patients with inflammatory arthritis. How best to wean patients from biologic therapy is an issue that comes up more frequently these days as patients increasingly achieve remission or low disease activity. In this slideshow, we highlight their considerations. Learn more   ADVERTISEMENT Biologic DMARD Tapering in RA Belgian researchers sought to determine which patients are appropriate candidates for tapering biologics. In this article, we summarize their findings. Learn more   Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis In rheumatoid arthritis patients who are in sustained remission and receiving conventional synthetic DMARDs, continued treatment with stable doses led to fewer disease activity flares and less frequent radiographic joint damage progression than tapered csDMARD treatment, shows a study. Learn more   MORE QUIZZES FROM RHEUMATOLOGY NETWORK • PsA Quiz: Monotherapy and Joint Destruction • PsA Quiz: Five forms of PsA • PSA Quiz: New Treatments   RHEUMATOLOGY HEALTHCARE JOB OPPORTUNITIES Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.